China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research report report published on Wednesday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

CPHI opened at $0.21 on Wednesday. The company has a 50-day moving average of $0.21 and a 200-day moving average of $0.21. China Pharma has a 1-year low of $0.13 and a 1-year high of $0.44. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.